Cargando…
Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS)
Polycystic ovary syndrome (PCOS) increases type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) with insulin resistance. We hypothesized that a 35 g whey preload would improve insulin sensitivity and glucose handling while reducing biomarkers associated with NAFLD. Twenty-nine age-matched w...
Autores principales: | Zumbro, Emily L., Rao, Manisha, Balcom-Luker, Shenavia, Broughton, K. Shane, LeMieux, Monique J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308637/ https://www.ncbi.nlm.nih.gov/pubmed/34371959 http://dx.doi.org/10.3390/nu13072451 |
Ejemplares similares
-
Reconsidering the Polycystic Ovary Syndrome (PCOS)
por: Gleicher, Norbert, et al.
Publicado: (2022) -
Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006) -
Polycystic Ovary Syndrome (PCOS) Transition at Menopause
por: Shah, Duru, et al.
Publicado: (2021) -
Molecular Research on Polycystic Ovary Syndrome (PCOS)
por: Daniele, Simona, et al.
Publicado: (2023) -
MicroRNAs Related to Polycystic Ovary Syndrome (PCOS)
por: Sørensen, Anja Elaine, et al.
Publicado: (2014)